Some participants in the TPP may indeed balk at being required to raise labor or environmental standards; in such case, however, policymakers need to ask whether these countries should get easier access to the US market. Similarly, access to affordable medicines is something other countries desperately need; it is large pharmaceutical companies that are not entirely enthusiastic.